Showing posts with label chemotherapy and ibrutinib offers longer life to b-cell cancer patients. Show all posts
Showing posts with label chemotherapy and ibrutinib offers longer life to b-cell cancer patients. Show all posts
Thursday, September 17, 2015

Combining targeted drug with chemotherapy offers longer life to b-cell cancer patients

›
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphoc...